CB-002, a breakthrough microbial ferment, offers a science-driven solution to calm microbes that can irritate the skin.
Consumer skincare relies on decades-old ingredients, leading to disengaged consumers and poorly differentiated brands. Consumers and leading brand builders want innovation.
New, differentiated ingredients aren’t just a competitive edge—they’re the future of skin, scalp, and body care.
Half of U.S. consumers seek microbiome-friendly skincare. Microbial ferments offer a natural source of differentiated, science-driven ingredients for the future of skincare.
CB-002 contains a rich ferment of skin-calming metabolites produced by a beneficial microbe.
Through >40M kChip data points, Concerto has learned how critical microbes implicated in skin health and disease (C. acnes, S. epidermidis, etc.) are influenced by combinations of skin microbes. This dataset serves as a goldmine for hit generation, fueling Concerto’s pipeline and strengthening a foundation for partnering around novel dermatology assets.
ENS-002 pacifies S. aureus virulence as a candidate therapeutic for atopic dermatitis.
Learn More About ENS-002ENS-003 inhibits C. albicans virulence—seeding Concerto’s understanding of how the vaginal microbiome maintains a healthy balance.
Learn More About ENS-003Concerto’s partners gain access to top-performing, differentiated products that add value to their portfolios. Partner with us to co-develop one of our existing assets. Inquire about the list of ingredient candidates we have waiting in the wings. Or propose a new product concept to co-discover together.
750 Main Street
Cambridge, MA 02139